MichalTKrauzeMDPhD
Oncology • Pittsburgh, PABreast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Division Chief Hematology /Oncology Hillman Cancer Center at UPMC Mercy
Dr. Krauze is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Locust St
Ste G103
Pittsburgh, PA 15219Phone+1 412-496-1717Fax+1 412-232-8150
Summary
- Dr. Michal Krauze is a seasoned oncologist based in Pittsburgh, PA, with subspecialties in breast cancer, gastrointestinal cancer, hematologic oncology, and thoracic cancer. He completed his residency in Internal Medicine at Montefiore Medical Center/Albert Einstein College of Medicine and a fellowship in Hematology and Medical Oncology at UPMC Medical Education. Dr. Krauze has extensive experience treating a variety of conditions, including breast cancer, prostate cancer, myeloproliferative disorders, myelodysplastic syndromes, and squamous cell carcinoma of the oropharynx. He is a well-cited contributor to oncology research with his works published in peer-reviewed journals such as Lancet, Melanoma Research, Frontiers in Oncology, Nanomedicine, and Cancer.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2009 - 2012
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2006 - 2009
University of Vienna Faculty of MedicineClass of 2003
Certifications & Licensure
PA State Medical License 2009 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Isolated Right Ventricular Metastasis of Hepatocellular Carcinoma: Clinical Findings and Histopathology of an Atypical Presentation.Aaron Yee Shuen See, Pulkit Kasiviswanathan, Masood Pasha Syed, Marta Minervini, Ibrahim Halil Sahin
JGH Open. 2024-12-01 - 1 citationsPatient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES...Jennifer L Steel, Charles J George, Lauren Terhorst, Jonathan G Yabes, Vincent Reyes
Lancet. 2024-04-06 - 3 citationsMelanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases.Dimitri G. Trembath, Anastasia Ivanova, Michal T. Krauze, John M. Kirkwood, Nana Nikolaishvilli-Feinberg
Melanoma Research. 2021-06-01
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
